Cardiac hemangiomas are rare cardiac neoplasia usually diagnosed in autopsies, from being asymptomatic to debuting with sudden death. The largest hemangioma published in the literature is of 130 mm size, we present the following case of a successful cardiac hemangioma excision of 280 × 35 mm in size, diagnosed due to recurrent cardiac symptoms.
Case presentation
A 48-year-old female patient, Jehovah’s Witness, with no previous diagnoses, is admitted due to recurrent syncopal episodes in the previous months. A transthoracic echocardiogram diagnosed a tumor in the right atrium and inferior vena cava producing a diastolic right ventricular, with preservation of the left ventricular ejection fraction at 55%. Given the high mortality risk, a surgical intervention was performed immediately. Successful excision was completed confirming a 280 × 35 mm mass without any complications, consistent with hemangioma on histopathology. Postoperative recovery showed no recurrence or complications.
Conclusions
Cardiac hemangiomas are rare and its clinical course can be varied from patient to patient. We present excision of a large cardiac mass with a high mortality risk due to its size and the patient’s spiritual beliefs.
Hinweise
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CPB
Cardiopulmonary bypass
CT
Computed tomography
MRI
Magnetic resonance image
Background
The first cardiac hemangioma case report was published by Uskoff in 1893 [1]. Although cardiac neoplasia are rare (0.28%), most are diagnosed in autopsies, with hemangiomas being only 5% of these cases [2]. Histologically, hemangiomas are classified in the principal categories: cavernous, capillary, and arteriovenous [3]. The physiopathology varies from patient to patient, some being completely asymptomatic while others debuting with sudden death. Miao and colleagues published a revision of 67 cases of cardiac hemangiomas with an average size of 52.3 mm, the largest being 130 mm, which to this day is the largest reported. We present the following case report of a successful 280 mm × 35 mm hemangioma excision that produced a right ventricular diastolic prolapse, proving a high mortality risk of the patient.
Case presentation
A 48-year-old female patient, with spiritual beliefs of Jehovah’s Witness, arrives into the emergency department due to multiple syncopal episodes the months prior, without any neurological deficits. A transthoracic echocardiogram was performed showing dilatation of the inferior vena cava and a < 50% collapse of an echogenic and heterogeneous image arising 13 cm from the right atrial opening occupying large part of it and producing a diastolic right ventricular prolapse (Fig. 1). This was a mobile longitudinal mass extending into the right chambers, despite this the left ventricular ejection fraction was preserved at 55%. Given the patient’s high complications risk due to embolism or sudden death, a surgical intervention was performed immediately.
Fig. 1
Transthoracic echocardiogram. Longitudinal view of the transthoracic echocardiogram showing a diastolic prolapse into the right ventricle (red arrows)
×
Anzeige
The surgery was performed with an on-pump beating-heart cardiopulmonary bypass (CPB) without aortic cross-clamping or cardioplegic arrest. A direct superior intravenous access into the superior vena cava was achieved as well as a peripheral femoral vein access with multipurpose of active drainage #25. The right atrium was accessed via a longitudinal incision parallel to the atria-ventricular groove. The cavity was explored confirming the 280 × 35 mm (length x width) mass that extended from the inferior vena cava to the right atrium. Excision was successfully performed without any complications (Fig. 2), the cavity was then explored with no evidence of thrombus or additional masses.
Fig. 2
Intraoperative hemangioma. Intraoperative specimen removed, 28 cm × 3.5 cm (length x width) mass
×
The patient had a successful postoperative recovery, a postoperative transthoracic echocardiogram was performed without evidence of any recidivating masses. The patient endured a 5-day in-hospital care and was discharged without any complications. The histologic report confirmed a hemangioma of arteriovenous type. Patient follow-up 3, 6, and 12-months later reported a SF-36 of 95% (minimal disability).
Discussion
Cardiac hemangiomas are rare primary cardiac tumors, with an incidence of only 1–2% of all cardiac primary tumors. These tumors are classified based on their histologic appearance in three categories: cavernous, capillary, and arteriovenous. The cavernous type has small vessels in its border with multiple dilations, the capillary type has numerous small-vessels similar to capillaries, while the arteriovenous has dysplasia of the arteries and veins [3]. This histological difference arises from hyperplasia or abnormal dilation of the small arterioles, venules, and capillaries [4]. They can appear at any stage of life and cardiac chamber, however they are most commonly found in the atrium. Although the clinical manifestations are varied, depending on the age of the patient, chamber localization, size, and rate of growth, most symptomatic patients have hemodynamic repercussions from valve, coronary vessels, or electrical pathways changes. Complex cases can involve other organs due to extrinsic compression, such as esophageal, tracheal, or ventricular prolapse like in this case report, resulting in high embolization risk.
Complementary images are of diagnostic use only, given that the definite diagnosis is histopathologic. However, an echocardiogram, computed tomography (CT) scan, CT angiography, or cardiac magnetic resonance image (MRI) will provide precise details that can be used in the operative approach. Given our patient’s clinical presentation and the high embolic or sudden death mortality risk, an immediate surgical excision was required. As of 2018, reports of Jehovah’s Witness supporters are estimated to be approximately 8 million worldwide, which as is common knowledge can be difficult to treat due to their beliefs in cardiac interventions [5]. However, in this case report a successful excision was completed without cardiac arrest with an on-pump beating-heart to minimize risks, achieving an excellent result with no reported complications short or long-term.
Anzeige
Previous reports of right chamber hemangiomas have recently been reported, however most have been of significant small sizes. Jiang et al. reported an excision of a right ventricular 68 × 50 × 26 mm mass without any hemodynamic repercussion [6]. Additionally Iida et al. also reported a 28.2 × 22.8 mass located in the right ventricle surface [7], as did Samanidis et al. with a 51 × 52 × 88 mm mass located in the right atrium without extension to any other chambers [8]. Lastly, Takahashi et al. did report a larger than usual hemangioma (60 × 60 mm) located in the left atrial appendage [9]. The importance of this case report reveals the compromise compared to other large hemangiomas, given that in our case report the mass affected the right chambers of the heart due its large size and subsequently proved a high-risk situation for the patient.
Conclusions
The incidence of cardiac hemangioma is low and its clinical course can be varied from patient to patient. We have described a unique case of a Jehovah’s Witness patient as well as a challenging and difficult surgical case. The key to proper management is a multidisciplinary approach as well as expertise and proper communication between physicians.
Acknowledgements
None.
Ethics approval and consent to participate
the Ethical and Research Committee of the Avidanti Clinic.
Consent for publication
Written consent was obtained from the patient for publication of this report. Any details identifying the individuals to the clinical history and images associated were eliminated as to remain anonymous.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Dr. med. Mihailo Andric Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
